# Prenetics to sell ACT Genomics stake to Delta Electronics for $46 million

Published 18/06/2025, 12:58
# Prenetics to sell ACT Genomics stake to Delta Electronics for $46 million

CHARLOTTE, N.C. - Prenetics Global Limited (NASDAQ:PRE) announced Wednesday it has entered into a definitive agreement to sell its majority stake in ACT Genomics to Delta Electronics, Inc. (TWSE:2308), a $35.1 billion market cap technology company with a "GREAT" financial health score according to InvestingPro, for approximately $46 million in cash.

The transaction, valued at up to $71.78 million for 100% of ACT Genomics, will boost Prenetics’ pro-forma cash reserves to approximately $86 million and increase its pro-forma short-term assets to about $117 million, according to the company’s press release statement. Delta Electronics brings strong fundamentals to the deal, with a healthy current ratio of 2.14 and 12.29% revenue growth in the last twelve months.

Following the divestment, Prenetics will focus on its consumer health brands: IM8, CircleDNA, and Europa. The company has raised its fiscal year 2025 revenue outlook to $80-$100 million from the previous guidance of $73-$85 million, citing strong performance from IM8. Want deeper insights into healthcare companies’ valuations and growth potential? InvestingPro offers exclusive financial metrics and professional analysis tools.

"This transaction is a testament to the value we have built within ACT Genomics and marks an important milestone for Prenetics," said Danny Yeung, CEO and Co-Founder of Prenetics.

The company reported its consumer health business achieved $14.4 million in revenue during the first quarter of 2025, representing a 336.5% increase year-over-year. Its flagship brand IM8, launched six months ago, has acquired over 55,000 customers and generated $5.7 million in revenue during Q1 2025.

Prenetics maintains a 35% stake in Insighta, an early cancer detection company, which the company values at $70 million based on a recent investment by Tencent.

The transaction is subject to customary closing conditions. Delta Electronics, a Taiwan-based provider of power management and smart green solutions, is expected to integrate ACT Genomics’ clinical diagnostics capabilities into its healthcare solutions portfolio.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.